Highline Wealth Partners’s Repligen RGEN Stock Holding History

Highline Wealth Partners’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-74	Closed	-$9.42K	–	1042
2025 Q1	$9.42K	Buy	+74	New	+$11.4K	﹤0.01%	323

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Highline Wealth Partners's RGEN Position: Q2 2025 in Review

Highline Wealth Partners sold out of Repligen (RGEN) in Q2 2025, closing a stake of 74 shares — an estimated $9.42K sold.

Highline Wealth Partners first reported a position in RGEN in Q1 2025 and held it in 1 quarter. The position peaked at $9.42K in Q1 2025. 444 funds tracked by Wall St. Rank hold RGEN as of Q2 2025.

Highline Wealth Partners reported no remaining Repligen position as of Q2 2025 after selling out during the quarter.
Highline Wealth Partners sold 74 Repligen shares in Q2 2025, an estimated $9.42K.
Highline Wealth Partners first reported a position in Repligen in Q1 2025 and held it in 1 quarter.
Highline Wealth Partners's Repligen position peaked at $9.42K in Q1 2025.
444 funds tracked by Wall St. Rank held Repligen as of Q2 2025.

Based on Highline Wealth Partners's 13F filing for Q2 2025, filed 16 Jul 2025.